Ryan Richardson
CIK: 0002054449
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AUTL
Autolus Therapeutics plc
Director
Discretionary Trading P&L
Holdings
About Richardson Ryan
Richardson Ryan (SEC CIK 0002054449) files insider reports with the SEC as Director of Autolus Therapeutics plc (AUTL).
Signal8 holds 2 ownership filings by Richardson Ryan (1 Form 3, 1 Form 4), filed between Mar 23, 2026 and Jul 1, 2026. Those filings report 2 transactions, the latest on Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Richardson Ryan's filings is in LONDON.
Recent filings by Richardson Ryan
- Jun 29, 2026: Grants or awards of AUTL derivative securities (2 lines, Form 4, code A).
Other insiders filing for Autolus Therapeutics plc (AUTL)
- Piccina Cintia, U.S. CCO & Country Gen Manager
- YOUNG WILLIAM D, Director
- Rao Madduri Ravin, Director
- Leiderman Elisabeth, Director
- Iannone Robert, Director
- BUTITTA CYNTHIA M, Director